Skip to content

Effect of Gabapentin on Idiopathic Subjective Tinnitus

Phase 2 Effect of Gabapentin on Idiopathic Subjective Tinnitus

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00555776
Enrollment
70
Registered
2007-11-09
Start date
2007-01-31
Completion date
2008-10-31
Last updated
2009-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective Tinnitus

Keywords

tinnitus, gabapentin

Brief summary

The purpose of this study is to determine wether Gabapentin which is useful for treating neuropathic pains, is effective on idiopathic subjective tinnitus.

Detailed description

Tinnitus is the perception of sound in the absence of acoustic stimulation. It can be subjective or objective. . Despite numerous researches,no effective treatment for people who suffer from tinnitus has yet been stablished. As there are many evidences suggesting that loss of inhibition in the central nervous system may be responsible for many aspects of auditory dysfunction,including tinnitus; and as Gabapentin (Neurontin), a gama-aminobutyric acid (GABA) analogue, is an effective medication in conditions where inhibition in the CNS is impaired; we guess that Gabapentin might be useful for treating idiopathic subjective tinnitus.

Interventions

DRUGGabapentin

Gabapentin, 600 mg bid for the first two weeks, increased to a maximum dose of 1800 mg per day during the next 6 weeks if necessary.

DRUGplacebo

placebo is given with the same definition as Gabapentin

Sponsors

Islamic Azad University of Mashhad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* patients with subjective idiopathic tinnitus

Exclusion criteria

* tinnitus with known underlying cause * pregnant women and patients younger than 18 or older than 75 years * patients with impaired renal function

Design outcomes

Primary

MeasureTime frame
Reduction in the sensation of Tinnitus by the patient or complete resolution of tinnitus;by the patient's scoring it from one to ten, before and after prescribing Gabapentin.two months

Secondary

MeasureTime frame
Relieve of complications of tinnitus, such as sleep difficulties.two months

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026